EHMT2 and cancer: To further explore the anti-cancer potential of G9a inhibition, we examined the anti-cancer effect of the G9a inhibitor BIX-01294 in vivo using xenograft transplant models in non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice.